Ready to Register?

MyLawCLE All-Access Pass

Best choice

Add the All-Access Pass and get this program —
plus 1,000+ live CLE programs every year.


All specialty & ethics credits included
38 practice areas
New sections: AI & the Law, Practice Management
100s of current and trending legal topics
Nationally recognized and highly experienced presenters

$395 / year — this program included
Register with the All-Access Pass

This program + 1,000+ CLE programs, all year

Or register for just this program

Live Video Broadcast

Live webinar of this one program.
$195 Register

On-Demand Video

Recorded access + self-study credit.
$195 Register

Caremark in 2026: Oversight Claims, Corporate Risk, and the High Bar for Bad Faith

A board’s oversight failure may create fiduciary liability for directors and officers. Learn to test reporting systems and red flags against the bad-faith standard, build oversight allegations from Section 220 materials, and challenge inadequately pleaded Caremark claims at dismissal.

2026-11-13 12:00:00

Program Details

2026-11-13 12:00:00

Program Details

2026-11-13 12:00:00

Over 1,000+ webinars

2026-11-13 12:00:00

Course Overview

Mismanagement Isn’t Enough — Caremark Liability Turns on Bad Faith

2026-11-13 12:00:00

Caremark oversight claims against directors and officers are not a remedy for every corporate misstep. The current standards separate ordinary corporate mismanagement from actionable bad-faith failures of oversight. Recent Delaware developments on oversight liability define where that line sits, and whether a claim survives depends on it.

Ignore a mission-critical risk, and the reporting system itself comes under scrutiny. Disregard a red flag, and an oversight failure may create fiduciary liability. Skip the Section 220 investigation, and the pre-suit record stays thin. Misjudge demand futility, and the derivative claim is at risk. Plead mismanagement instead of bad faith, and the claim invites dismissal.

You will walk out with a working framework for testing board and officer oversight—reporting systems, internal controls, and red flags—against the bad-faith standard. You will see how Section 220 materials become oversight allegations and how defendants challenge inadequately pleaded claims at the pleading stage. Those are record-specific judgment calls no template can make for you.

Format

CLE Credit

2h CLE Credits

Level

Intermediate

Length

2

Key topics that will be covered

01
The Bad-Faith Threshold
How Caremark’s two oversight theories and the bad-faith standard separate actionable oversight failures from ordinary corporate mismanagement in the claims you bring or defend.
02
Board and Officer Duties
How the oversight responsibilities of directors and officers shape what each must monitor and when an oversight failure may create fiduciary liability.
03
Reporting Systems and Controls
How to evaluate corporate reporting systems and internal controls for mission-critical risks before an oversight claim tests them.
04
Red Flags That Count
How to judge when red flags support an oversight claim and when they fall short of the bad-faith standard.
05
From Section 220 to Pleading
How Section 220 materials develop the pre-suit record and how demand futility affects the pleading of oversight failures in derivative claims.
06
Defense and Recent Lessons
How defendants challenge inadequately pleaded Caremark claims at the pleading stage, drawing on recent Delaware developments and practical lessons from recent oversight litigation.

Program schedule

clock 12:00 pm - 1:00 pm EST

Caremark Oversight Claims: Red Flags, Reporting Systems, and Fiduciary Duties

This session will examine the current standards governing Caremark oversight claims against directors and officers, focusing on the distinction between ordinary corporate mismanagement and actionable bad-faith failures of oversight. The discussion will explore corporate reporting systems, mission-critical risks, red flags, and the circumstances under which oversight failures may create fiduciary liability.

Matthew D. StachelMatthew D. Stachel
Miranda GilbertMiranda Gilbert
clock 1:10 pm - 2:10 pm EST

Building and Defending Caremark Claims: From Section 220 to Dismissal

This session will focus on the litigation path from a stockholder’s pre-suit investigation through pleading and dismissal of a Caremark claim. Attorneys will examine how Section 220 materials can be used to develop oversight allegations, how demand futility affects derivative claims, and the strategies available to defendants challenging inadequately pleaded oversight claims.

Matthew D. StachelMatthew D. Stachel
Miranda GilbertMiranda Gilbert
Matthew D. Stachel

Matthew D. Stachel

Paul, Weiss, Rifkind, Wharton & Garrison LLP

Miranda Gilbert

Miranda Gilbert

Paul, Weiss, Rifkind, Wharton & Garrison LLP

Matthew D. Stachel

Matthew D. Stachel

Paul, Weiss, Rifkind, Wharton & Garrison LLP

Matthew D. Stachel is a partner in the Litigation Department of Paul, Weiss, Rifkind, Wharton & Garrison LLP. His practice focuses on complex corporate and commercial litigation, including fiduciary-duty claims involving directors, officers, and controlling stockholders; shareholder derivative actions; mergers and acquisitions disputes; and securities litigation. He represents companies, directors, officers, and board committees in high-stakes disputes involving corporate governance and management decisions.

Education & Credentials

Matthew earned his B.A. from the College of William & Mary and his J.D. from the University of Virginia School of Law. He is admitted to practice in Delaware.

Recognition & Leadership

Matthew advises public companies, boards of directors, special board committees, and private equity investors and their portfolio companies on their rights and obligations under Delaware law. His representative matters include defending directors and officers in shareholder derivative litigation and representing special committees in disputes concerning significant corporate transactions, including the proposed sale of Pattern Energy Group to the Canada Pension Plan Investment Board.

Professional Involvement

Matthew contributes to Paul, Weiss publications addressing corporate litigation and fiduciary-duty issues. He is listed among the lawyers associated with the firm's March 2023 client memorandum, “Delaware Court of Chancery Dismisses Caremark Claims Against Directors for Failure to Allege Bad Faith Conduct.” The memorandum examines the pleading standards for Caremark oversight claims and allegations of bad faith, topics relevant to corporate governance and director oversight.

Experience

Matthew's litigation experience includes defending The Kraft Heinz Company and current or former officers and directors in derivative actions, representing Teladoc Health in obtaining dismissal of derivative claims, and representing Snap, Inc. and several of its directors and executives in derivative actions concerning the company's preparation for Apple's privacy changes. His other derivative-litigation matters include Alexion Pharmaceuticals, Nikola Corporation, World Wrestling Entertainment, and NextEra Energy.

He has also represented directors and officers in fiduciary-duty disputes arising from major corporate transactions, including Bioverativ's $11.6 billion sale to Sanofi and the $43 billion WarnerMedia–Discovery merger. In other complex commercial and securities matters, he represented ExxonMobil and certain former executives in defeating a $3 billion securities fraud case at trial and International Construction Products in securing a $100 million jury verdict against Caterpillar.
Miranda Gilbert

Miranda Gilbert

Paul, Weiss, Rifkind, Wharton & Garrison LLP

Miranda N. Gilbert is a Wilmington-based associate in the Litigation Department of Paul, Weiss, Rifkind, Wharton & Garrison LLP. Her practice focuses on high-stakes corporate and commercial disputes, particularly those governed by Delaware law. She represents corporations, boards of directors, special committees, and individual fiduciaries in litigation involving alleged breaches of fiduciary duty, corporate governance disputes, books-and-records demands, and other matters concerning the rights and obligations of corporate decision-makers.

Education & Credentials

She earned her J.D., cum laude, from William & Mary Law School and her B.A., summa cum laude, from the University of North Carolina at Greensboro. She is admitted to the bar in Delaware.

Recognition & Leadership

Paul, Weiss recognizes Miranda for her ability to distill complex statutory and common-law issues into clear legal arguments grounded in Delaware corporate jurisprudence. Her practice involves disputes requiring careful analysis of fiduciary obligations and the legal standards governing corporate decisionmaking.

Professional Involvement

Miranda practices within Paul, Weiss's Litigation, Mergers & Acquisitions Litigation, and Corporate Governance groups, reflecting her work at the intersection of corporate litigation, fiduciary duties, and governance-related disputes.

Experience

Miranda has extensive experience litigating matters before the Delaware Court of Chancery, the Complex Commercial Litigation Division of the Delaware Superior Court, the Delaware Supreme Court, and federal courts. Her work includes actions involving alleged breaches of fiduciary duty, advancement and indemnification claims, books-and-records demands, disputed corporate transactions, fraud, and breach of contract. Before joining Paul, Weiss, she handled complex corporate and commercial litigation at another Delaware law firm. Earlier in her career, she served as a judicial extern to two judges of the United States District Court for the Eastern District of Virginia.
Matthew D. Stachel

Matthew D. Stachel

Paul, Weiss, Rifkind, Wharton & Garrison LLP

Matthew D. Stachel is a partner in the Litigation Department of Paul, Weiss, Rifkind, Wharton & Garrison LLP. His practice focuses on complex corporate and commercial litigation, including fiduciary-duty claims involving directors, officers, and controlling stockholders; shareholder derivative actions; mergers and acquisitions disputes; and securities litigation. He represents companies, directors, officers, and board committees in high-stakes disputes involving corporate governance and management decisions.

Education & Credentials

Matthew earned his B.A. from the College of William & Mary and his J.D. from the University of Virginia School of Law. He is admitted to practice in Delaware.

Recognition & Leadership

Matthew advises public companies, boards of directors, special board committees, and private equity investors and their portfolio companies on their rights and obligations under Delaware law. His representative matters include defending directors and officers in shareholder derivative litigation and representing special committees in disputes concerning significant corporate transactions, including the proposed sale of Pattern Energy Group to the Canada Pension Plan Investment Board.

Professional Involvement

Matthew contributes to Paul, Weiss publications addressing corporate litigation and fiduciary-duty issues. He is listed among the lawyers associated with the firm's March 2023 client memorandum, “Delaware Court of Chancery Dismisses Caremark Claims Against Directors for Failure to Allege Bad Faith Conduct.” The memorandum examines the pleading standards for Caremark oversight claims and allegations of bad faith, topics relevant to corporate governance and director oversight.

Experience

Matthew's litigation experience includes defending The Kraft Heinz Company and current or former officers and directors in derivative actions, representing Teladoc Health in obtaining dismissal of derivative claims, and representing Snap, Inc. and several of its directors and executives in derivative actions concerning the company's preparation for Apple's privacy changes. His other derivative-litigation matters include Alexion Pharmaceuticals, Nikola Corporation, World Wrestling Entertainment, and NextEra Energy.

He has also represented directors and officers in fiduciary-duty disputes arising from major corporate transactions, including Bioverativ's $11.6 billion sale to Sanofi and the $43 billion WarnerMedia–Discovery merger. In other complex commercial and securities matters, he represented ExxonMobil and certain former executives in defeating a $3 billion securities fraud case at trial and International Construction Products in securing a $100 million jury verdict against Caterpillar.
Miranda Gilbert

Miranda Gilbert

Paul, Weiss, Rifkind, Wharton & Garrison LLP

Miranda N. Gilbert is a Wilmington-based associate in the Litigation Department of Paul, Weiss, Rifkind, Wharton & Garrison LLP. Her practice focuses on high-stakes corporate and commercial disputes, particularly those governed by Delaware law. She represents corporations, boards of directors, special committees, and individual fiduciaries in litigation involving alleged breaches of fiduciary duty, corporate governance disputes, books-and-records demands, and other matters concerning the rights and obligations of corporate decision-makers.

Education & Credentials

She earned her J.D., cum laude, from William & Mary Law School and her B.A., summa cum laude, from the University of North Carolina at Greensboro. She is admitted to the bar in Delaware.

Recognition & Leadership

Paul, Weiss recognizes Miranda for her ability to distill complex statutory and common-law issues into clear legal arguments grounded in Delaware corporate jurisprudence. Her practice involves disputes requiring careful analysis of fiduciary obligations and the legal standards governing corporate decisionmaking.

Professional Involvement

Miranda practices within Paul, Weiss's Litigation, Mergers & Acquisitions Litigation, and Corporate Governance groups, reflecting her work at the intersection of corporate litigation, fiduciary duties, and governance-related disputes.

Experience

Miranda has extensive experience litigating matters before the Delaware Court of Chancery, the Complex Commercial Litigation Division of the Delaware Superior Court, the Delaware Supreme Court, and federal courts. Her work includes actions involving alleged breaches of fiduciary duty, advancement and indemnification claims, books-and-records demands, disputed corporate transactions, fraud, and breach of contract. Before joining Paul, Weiss, she handled complex corporate and commercial litigation at another Delaware law firm. Earlier in her career, she served as a judicial extern to two judges of the United States District Court for the Eastern District of Virginia.

Credits by state

AK2.0
AL2.0
AR2.0
AZ2.0
CA2.0
CO2.0
CT2.0
DC2.0
DE2.0
FL2.0
GA2.0
HI2.0
IA2.0
ID2.0
IL2.0
IN2.0
KS2.0
KY2.0
LA2.0
MA2.0
MD2.0
ME2.0
MI2.0
MN2.0
MO2.4
MS2.0
MT2.0
NC2.0
ND2.0
NE2.0
NH120.0
NJ2.0
NM2.0
NV2.0
NY2.0
OH2.0
OK2.5
OR2.0
PA2.0
RI2.5
SC2.0
SD2.0
TN2.0
TX2.0
UT2.0
VA2.0
VT2.0
WA2.0
WI2.0
WV2.4
WY2.0

Upcoming Live Online CLE Broadcasts

1000+

Live stream programs

24/7

Access to live webinars & recordings

70,000+

Trusted by Legal Professionals

1000+

Live stream programs

24/7

Access to live webinars & recordings

70,000+

Trusted by Legal Professionals

1000+

Live stream programs

24/7

Access to live webinars & recordings

10,000+

Trusted by Legal Professionals

1000+

Live stream programs

24/7

Access to live webinars & recordings

70,000+

Trusted by Legal Professionals

MCLE Credits

Alabama
Approved
Alaska
Approved
Arizona
Approved
Arkansas
Approved
California
Approved
Colorado
Pending
Connecticut
Approved
Delaware
Pending
District of Columbia
No Required
Florida
Approved
Georgia
Pending
Hawaii
Approved
Idaho
Pending
Illinois
Pending
Indiana
Pending
Iowa
Pending
Kansas
Pending
Kentucky
Pending
Louisiana
Pending
Maine
Pending
Maryland
No Required
Massachusetts
No Required
Michigan
No Required
Minnesota
Pending
Mississippi
Pending
Missouri
Approved
Montana
Pending
Nebraska
Pending
Nevada
Pending
New Hampshire
Approved
New Jersey
Approved
New Mexico
Approved
New York
Approved
North Carolina
Pending
North Dakota
Approved
Ohio
Approved
Oklahoma
Pending
Oregon
Pending
Pennsylvania
Approved
Rhode Island
Pending
South Carolina
Pending
South Dakota
No Required
Tennessee
Approved
Texas
Approved
Utah
Pending
Vermont
Approved
Virginia
Not Eligible
Washington
Approved
West Virginia
Pending
Wisconsin
Pending
Wyoming
Pending

Alabama

Requirements

The Alabama State Bar MCLE Commission requires attorneys to complete 12 credits, including 1 ethics, by December 31 of each year. All credits must be reported by February 15 of the following year. A maximum of 12 credits, including 1 ethics credit, may be carried over for 1 year only.  

Formats

  • Attorneys can earn unlimited “live” credit through live seminars, live webcasts, and co-sponsored locations with MyLAWCLE-Alabama approved programs
  • Attorneys are limited to 6 credits per compliance period of “online” programs through MyLAwCLE On-Demand programs